Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Dramatic antitumor effects of the dual MET/RON small-molecule inhibitor LY2801653 in non-small cell lung cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Dramatic antitumor effects of the dual MET/RON small-molecule inhibitor LY2801653 in non-small cell lung cancer.
Dramatic antitumor effects of the dual MET/RON small-molecule inhibitor LY2801653 in non-small cell lung cancer. Cancer Res. 2014 Feb 01; 74(3):884-95.
View in:
PubMed
subject areas
Amino Acid Sequence
Animals
Carcinoma, Non-Small-Cell Lung
Cell Line, Tumor
Cell Proliferation
Disease Models, Animal
Enzyme Activation
Female
Gene Expression
Gene Expression Regulation, Neoplastic
Gene Regulatory Networks
Humans
Indazoles
Lung Neoplasms
Mice
Niacinamide
Peptides
Proto-Oncogene Proteins c-met
Receptor Protein-Tyrosine Kinases
STAT3 Transcription Factor
Tumor Burden
Xenograft Model Antitumor Assays
authors with profiles
Everett E. Vokes
Ravi Salgia
Rifat Hasina
Aliya Husain